1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Novel Coronavirus Inactivated Vaccine Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Novel Coronavirus Inactivated Vaccine by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Novel Coronavirus Inactivated Vaccine by Country/Region, 2020, 2024 & 2031 2.2 Novel Coronavirus Inactivated Vaccine Segment by Type 2.2.1 Adult 2.2.2 Child 2.3 Novel Coronavirus Inactivated Vaccine Sales by Type 2.3.1 Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Type (2020-2025) 2.3.2 Global Novel Coronavirus Inactivated Vaccine Revenue and Market Share by Type (2020-2025) 2.3.3 Global Novel Coronavirus Inactivated Vaccine Sale Price by Type (2020-2025) 2.4 Novel Coronavirus Inactivated Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Clinic 2.5 Novel Coronavirus Inactivated Vaccine Sales by Application 2.5.1 Global Novel Coronavirus Inactivated Vaccine Sale Market Share by Application (2020-2025) 2.5.2 Global Novel Coronavirus Inactivated Vaccine Revenue and Market Share by Application (2020-2025) 2.5.3 Global Novel Coronavirus Inactivated Vaccine Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Novel Coronavirus Inactivated Vaccine Breakdown Data by Company 3.1.1 Global Novel Coronavirus Inactivated Vaccine Annual Sales by Company (2020-2025) 3.1.2 Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Company (2020-2025) 3.2 Global Novel Coronavirus Inactivated Vaccine Annual Revenue by Company (2020-2025) 3.2.1 Global Novel Coronavirus Inactivated Vaccine Revenue by Company (2020-2025) 3.2.2 Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Company (2020-2025) 3.3 Global Novel Coronavirus Inactivated Vaccine Sale Price by Company 3.4 Key Manufacturers Novel Coronavirus Inactivated Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Novel Coronavirus Inactivated Vaccine Product Location Distribution 3.4.2 Players Novel Coronavirus Inactivated Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Novel Coronavirus Inactivated Vaccine by Geographic Region 4.1 World Historic Novel Coronavirus Inactivated Vaccine Market Size by Geographic Region (2020-2025) 4.1.1 Global Novel Coronavirus Inactivated Vaccine Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Novel Coronavirus Inactivated Vaccine Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Novel Coronavirus Inactivated Vaccine Market Size by Country/Region (2020-2025) 4.2.1 Global Novel Coronavirus Inactivated Vaccine Annual Sales by Country/Region (2020-2025) 4.2.2 Global Novel Coronavirus Inactivated Vaccine Annual Revenue by Country/Region (2020-2025) 4.3 Americas Novel Coronavirus Inactivated Vaccine Sales Growth 4.4 APAC Novel Coronavirus Inactivated Vaccine Sales Growth 4.5 Europe Novel Coronavirus Inactivated Vaccine Sales Growth 4.6 Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales Growth 5 Americas 5.1 Americas Novel Coronavirus Inactivated Vaccine Sales by Country 5.1.1 Americas Novel Coronavirus Inactivated Vaccine Sales by Country (2020-2025) 5.1.2 Americas Novel Coronavirus Inactivated Vaccine Revenue by Country (2020-2025) 5.2 Americas Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) 5.3 Americas Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Novel Coronavirus Inactivated Vaccine Sales by Region 6.1.1 APAC Novel Coronavirus Inactivated Vaccine Sales by Region (2020-2025) 6.1.2 APAC Novel Coronavirus Inactivated Vaccine Revenue by Region (2020-2025) 6.2 APAC Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) 6.3 APAC Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Novel Coronavirus Inactivated Vaccine by Country 7.1.1 Europe Novel Coronavirus Inactivated Vaccine Sales by Country (2020-2025) 7.1.2 Europe Novel Coronavirus Inactivated Vaccine Revenue by Country (2020-2025) 7.2 Europe Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) 7.3 Europe Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Novel Coronavirus Inactivated Vaccine by Country 8.1.1 Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales by Country (2020-2025) 8.1.2 Middle East & Africa Novel Coronavirus Inactivated Vaccine Revenue by Country (2020-2025) 8.2 Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) 8.3 Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Novel Coronavirus Inactivated Vaccine 10.3 Manufacturing Process Analysis of Novel Coronavirus Inactivated Vaccine 10.4 Industry Chain Structure of Novel Coronavirus Inactivated Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Novel Coronavirus Inactivated Vaccine Distributors 11.3 Novel Coronavirus Inactivated Vaccine Customer 12 World Forecast Review for Novel Coronavirus Inactivated Vaccine by Geographic Region 12.1 Global Novel Coronavirus Inactivated Vaccine Market Size Forecast by Region 12.1.1 Global Novel Coronavirus Inactivated Vaccine Forecast by Region (2026-2031) 12.1.2 Global Novel Coronavirus Inactivated Vaccine Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Novel Coronavirus Inactivated Vaccine Forecast by Type (2026-2031) 12.7 Global Novel Coronavirus Inactivated Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Inovio Pharmaceuticals 13.1.1 Inovio Pharmaceuticals Company Information 13.1.2 Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.1.3 Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Inovio Pharmaceuticals Main Business Overview 13.1.5 Inovio Pharmaceuticals Latest Developments 13.2 Moderna 13.2.1 Moderna Company Information 13.2.2 Moderna Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.2.3 Moderna Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 Moderna Main Business Overview 13.2.5 Moderna Latest Developments 13.3 GlaxoSmithKine 13.3.1 GlaxoSmithKine Company Information 13.3.2 GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.3.3 GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 GlaxoSmithKine Main Business Overview 13.3.5 GlaxoSmithKine Latest Developments 13.4 Pfizer 13.4.1 Pfizer Company Information 13.4.2 Pfizer Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.4.3 Pfizer Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Pfizer Main Business Overview 13.4.5 Pfizer Latest Developments 13.5 Johnson&Johnson 13.5.1 Johnson&Johnson Company Information 13.5.2 Johnson&Johnson Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.5.3 Johnson&Johnson Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 Johnson&Johnson Main Business Overview 13.5.5 Johnson&Johnson Latest Developments 13.6 Heat Biologics 13.6.1 Heat Biologics Company Information 13.6.2 Heat Biologics Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.6.3 Heat Biologics Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Heat Biologics Main Business Overview 13.6.5 Heat Biologics Latest Developments 13.7 Sanofi 13.7.1 Sanofi Company Information 13.7.2 Sanofi Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.7.3 Sanofi Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Sanofi Main Business Overview 13.7.5 Sanofi Latest Developments 13.8 Beijing Institute of Biological Products Co., Ltd 13.8.1 Beijing Institute of Biological Products Co., Ltd Company Information 13.8.2 Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.8.3 Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Beijing Institute of Biological Products Co., Ltd Main Business Overview 13.8.5 Beijing Institute of Biological Products Co., Ltd Latest Developments 13.9 Beijing Kexing Zhongwei Biotechnology Co., Ltd 13.9.1 Beijing Kexing Zhongwei Biotechnology Co., Ltd Company Information 13.9.2 Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.9.3 Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Beijing Kexing Zhongwei Biotechnology Co., Ltd Main Business Overview 13.9.5 Beijing Kexing Zhongwei Biotechnology Co., Ltd Latest Developments 13.10 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd 13.10.1 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Company Information 13.10.2 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.10.3 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Main Business Overview 13.10.5 Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Latest Developments 13.11 Wuhan Institute of Biological Products Co., Ltd 13.11.1 Wuhan Institute of Biological Products Co., Ltd Company Information 13.11.2 Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications 13.11.3 Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) 13.11.4 Wuhan Institute of Biological Products Co., Ltd Main Business Overview 13.11.5 Wuhan Institute of Biological Products Co., Ltd Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Novel Coronavirus Inactivated Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Novel Coronavirus Inactivated Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Adult Table 4. Major Players of Child Table 5. Global Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) & (K Units) Table 6. Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Type (2020-2025) Table 7. Global Novel Coronavirus Inactivated Vaccine Revenue by Type (2020-2025) & ($ million) Table 8. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Type (2020-2025) Table 9. Global Novel Coronavirus Inactivated Vaccine Sale Price by Type (2020-2025) & (US$/Unit) Table 10. Global Novel Coronavirus Inactivated Vaccine Sale by Application (2020-2025) & (K Units) Table 11. Global Novel Coronavirus Inactivated Vaccine Sale Market Share by Application (2020-2025) Table 12. Global Novel Coronavirus Inactivated Vaccine Revenue by Application (2020-2025) & ($ million) Table 13. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Application (2020-2025) Table 14. Global Novel Coronavirus Inactivated Vaccine Sale Price by Application (2020-2025) & (US$/Unit) Table 15. Global Novel Coronavirus Inactivated Vaccine Sales by Company (2020-2025) & (K Units) Table 16. Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Company (2020-2025) Table 17. Global Novel Coronavirus Inactivated Vaccine Revenue by Company (2020-2025) & ($ millions) Table 18. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Company (2020-2025) Table 19. Global Novel Coronavirus Inactivated Vaccine Sale Price by Company (2020-2025) & (US$/Unit) Table 20. Key Manufacturers Novel Coronavirus Inactivated Vaccine Producing Area Distribution and Sales Area Table 21. Players Novel Coronavirus Inactivated Vaccine Products Offered Table 22. Novel Coronavirus Inactivated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Novel Coronavirus Inactivated Vaccine Sales by Geographic Region (2020-2025) & (K Units) Table 26. Global Novel Coronavirus Inactivated Vaccine Sales Market Share Geographic Region (2020-2025) Table 27. Global Novel Coronavirus Inactivated Vaccine Revenue by Geographic Region (2020-2025) & ($ millions) Table 28. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Geographic Region (2020-2025) Table 29. Global Novel Coronavirus Inactivated Vaccine Sales by Country/Region (2020-2025) & (K Units) Table 30. Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Country/Region (2020-2025) Table 31. Global Novel Coronavirus Inactivated Vaccine Revenue by Country/Region (2020-2025) & ($ millions) Table 32. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Country/Region (2020-2025) Table 33. Americas Novel Coronavirus Inactivated Vaccine Sales by Country (2020-2025) & (K Units) Table 34. Americas Novel Coronavirus Inactivated Vaccine Sales Market Share by Country (2020-2025) Table 35. Americas Novel Coronavirus Inactivated Vaccine Revenue by Country (2020-2025) & ($ millions) Table 36. Americas Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) & (K Units) Table 37. Americas Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) & (K Units) Table 38. APAC Novel Coronavirus Inactivated Vaccine Sales by Region (2020-2025) & (K Units) Table 39. APAC Novel Coronavirus Inactivated Vaccine Sales Market Share by Region (2020-2025) Table 40. APAC Novel Coronavirus Inactivated Vaccine Revenue by Region (2020-2025) & ($ millions) Table 41. APAC Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) & (K Units) Table 42. APAC Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) & (K Units) Table 43. Europe Novel Coronavirus Inactivated Vaccine Sales by Country (2020-2025) & (K Units) Table 44. Europe Novel Coronavirus Inactivated Vaccine Revenue by Country (2020-2025) & ($ millions) Table 45. Europe Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) & (K Units) Table 46. Europe Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) & (K Units) Table 47. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales by Country (2020-2025) & (K Units) Table 48. Middle East & Africa Novel Coronavirus Inactivated Vaccine Revenue Market Share by Country (2020-2025) Table 49. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales by Type (2020-2025) & (K Units) Table 50. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales by Application (2020-2025) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of Novel Coronavirus Inactivated Vaccine Table 52. Key Market Challenges & Risks of Novel Coronavirus Inactivated Vaccine Table 53. Key Industry Trends of Novel Coronavirus Inactivated Vaccine Table 54. Novel Coronavirus Inactivated Vaccine Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Novel Coronavirus Inactivated Vaccine Distributors List Table 57. Novel Coronavirus Inactivated Vaccine Customer List Table 58. Global Novel Coronavirus Inactivated Vaccine Sales Forecast by Region (2026-2031) & (K Units) Table 59. Global Novel Coronavirus Inactivated Vaccine Revenue Forecast by Region (2026-2031) & ($ millions) Table 60. Americas Novel Coronavirus Inactivated Vaccine Sales Forecast by Country (2026-2031) & (K Units) Table 61. Americas Novel Coronavirus Inactivated Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 62. APAC Novel Coronavirus Inactivated Vaccine Sales Forecast by Region (2026-2031) & (K Units) Table 63. APAC Novel Coronavirus Inactivated Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 64. Europe Novel Coronavirus Inactivated Vaccine Sales Forecast by Country (2026-2031) & (K Units) Table 65. Europe Novel Coronavirus Inactivated Vaccine Revenue Forecast by Country (2026-2031) & ($ millions) Table 66. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales Forecast by Country (2026-2031) & (K Units) Table 67. Middle East & Africa Novel Coronavirus Inactivated Vaccine Revenue Forecast by Country (2026-2031) & ($ millions) Table 68. Global Novel Coronavirus Inactivated Vaccine Sales Forecast by Type (2026-2031) & (K Units) Table 69. Global Novel Coronavirus Inactivated Vaccine Revenue Forecast by Type (2026-2031) & ($ millions) Table 70. Global Novel Coronavirus Inactivated Vaccine Sales Forecast by Application (2026-2031) & (K Units) Table 71. Global Novel Coronavirus Inactivated Vaccine Revenue Forecast by Application (2026-2031) & ($ millions) Table 72. Inovio Pharmaceuticals Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 73. Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 74. Inovio Pharmaceuticals Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 75. Inovio Pharmaceuticals Main Business Table 76. Inovio Pharmaceuticals Latest Developments Table 77. Moderna Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 78. Moderna Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 79. Moderna Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 80. Moderna Main Business Table 81. Moderna Latest Developments Table 82. GlaxoSmithKine Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 83. GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 84. GlaxoSmithKine Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 85. GlaxoSmithKine Main Business Table 86. GlaxoSmithKine Latest Developments Table 87. Pfizer Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 88. Pfizer Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 89. Pfizer Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 90. Pfizer Main Business Table 91. Pfizer Latest Developments Table 92. Johnson&Johnson Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 93. Johnson&Johnson Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 94. Johnson&Johnson Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 95. Johnson&Johnson Main Business Table 96. Johnson&Johnson Latest Developments Table 97. Heat Biologics Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 98. Heat Biologics Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 99. Heat Biologics Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 100. Heat Biologics Main Business Table 101. Heat Biologics Latest Developments Table 102. Sanofi Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 103. Sanofi Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 104. Sanofi Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 105. Sanofi Main Business Table 106. Sanofi Latest Developments Table 107. Beijing Institute of Biological Products Co., Ltd Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 108. Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 109. Beijing Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 110. Beijing Institute of Biological Products Co., Ltd Main Business Table 111. Beijing Institute of Biological Products Co., Ltd Latest Developments Table 112. Beijing Kexing Zhongwei Biotechnology Co., Ltd Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 113. Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 114. Beijing Kexing Zhongwei Biotechnology Co., Ltd Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 115. Beijing Kexing Zhongwei Biotechnology Co., Ltd Main Business Table 116. Beijing Kexing Zhongwei Biotechnology Co., Ltd Latest Developments Table 117. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 118. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 119. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 120. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Main Business Table 121. Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd Latest Developments Table 122. Wuhan Institute of Biological Products Co., Ltd Basic Information, Novel Coronavirus Inactivated Vaccine Manufacturing Base, Sales Area and Its Competitors Table 123. Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Product Portfolios and Specifications Table 124. Wuhan Institute of Biological Products Co., Ltd Novel Coronavirus Inactivated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 125. Wuhan Institute of Biological Products Co., Ltd Main Business Table 126. Wuhan Institute of Biological Products Co., Ltd Latest Developments List of Figures Figure 1. Picture of Novel Coronavirus Inactivated Vaccine Figure 2. Novel Coronavirus Inactivated Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Novel Coronavirus Inactivated Vaccine Sales Growth Rate 2020-2031 (K Units) Figure 7. Global Novel Coronavirus Inactivated Vaccine Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Novel Coronavirus Inactivated Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Novel Coronavirus Inactivated Vaccine Sales Market Share by Country/Region (2024) Figure 10. Novel Coronavirus Inactivated Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Adult Figure 12. Product Picture of Child Figure 13. Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Type in 2025 Figure 14. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Type (2020-2025) Figure 15. Novel Coronavirus Inactivated Vaccine Consumed in Hospital Figure 16. Global Novel Coronavirus Inactivated Vaccine Market: Hospital (2020-2025) & (K Units) Figure 17. Novel Coronavirus Inactivated Vaccine Consumed in Clinic Figure 18. Global Novel Coronavirus Inactivated Vaccine Market: Clinic (2020-2025) & (K Units) Figure 19. Global Novel Coronavirus Inactivated Vaccine Sale Market Share by Application (2024) Figure 20. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Application in 2025 Figure 21. Novel Coronavirus Inactivated Vaccine Sales by Company in 2025 (K Units) Figure 22. Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Company in 2025 Figure 23. Novel Coronavirus Inactivated Vaccine Revenue by Company in 2025 ($ millions) Figure 24. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Company in 2025 Figure 25. Global Novel Coronavirus Inactivated Vaccine Sales Market Share by Geographic Region (2020-2025) Figure 26. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share by Geographic Region in 2025 Figure 27. Americas Novel Coronavirus Inactivated Vaccine Sales 2020-2025 (K Units) Figure 28. Americas Novel Coronavirus Inactivated Vaccine Revenue 2020-2025 ($ millions) Figure 29. APAC Novel Coronavirus Inactivated Vaccine Sales 2020-2025 (K Units) Figure 30. APAC Novel Coronavirus Inactivated Vaccine Revenue 2020-2025 ($ millions) Figure 31. Europe Novel Coronavirus Inactivated Vaccine Sales 2020-2025 (K Units) Figure 32. Europe Novel Coronavirus Inactivated Vaccine Revenue 2020-2025 ($ millions) Figure 33. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales 2020-2025 (K Units) Figure 34. Middle East & Africa Novel Coronavirus Inactivated Vaccine Revenue 2020-2025 ($ millions) Figure 35. Americas Novel Coronavirus Inactivated Vaccine Sales Market Share by Country in 2025 Figure 36. Americas Novel Coronavirus Inactivated Vaccine Revenue Market Share by Country (2020-2025) Figure 37. Americas Novel Coronavirus Inactivated Vaccine Sales Market Share by Type (2020-2025) Figure 38. Americas Novel Coronavirus Inactivated Vaccine Sales Market Share by Application (2020-2025) Figure 39. United States Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 40. Canada Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 41. Mexico Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 42. Brazil Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 43. APAC Novel Coronavirus Inactivated Vaccine Sales Market Share by Region in 2025 Figure 44. APAC Novel Coronavirus Inactivated Vaccine Revenue Market Share by Region (2020-2025) Figure 45. APAC Novel Coronavirus Inactivated Vaccine Sales Market Share by Type (2020-2025) Figure 46. APAC Novel Coronavirus Inactivated Vaccine Sales Market Share by Application (2020-2025) Figure 47. China Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 48. Japan Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 49. South Korea Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 50. Southeast Asia Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 51. India Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 52. Australia Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 53. China Taiwan Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 54. Europe Novel Coronavirus Inactivated Vaccine Sales Market Share by Country in 2025 Figure 55. Europe Novel Coronavirus Inactivated Vaccine Revenue Market Share by Country (2020-2025) Figure 56. Europe Novel Coronavirus Inactivated Vaccine Sales Market Share by Type (2020-2025) Figure 57. Europe Novel Coronavirus Inactivated Vaccine Sales Market Share by Application (2020-2025) Figure 58. Germany Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 59. France Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 60. UK Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 61. Italy Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 62. Russia Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 63. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales Market Share by Country (2020-2025) Figure 64. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales Market Share by Type (2020-2025) Figure 65. Middle East & Africa Novel Coronavirus Inactivated Vaccine Sales Market Share by Application (2020-2025) Figure 66. Egypt Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 67. South Africa Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 68. Israel Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 69. Turkey Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 70. GCC Countries Novel Coronavirus Inactivated Vaccine Revenue Growth 2020-2025 ($ millions) Figure 71. Manufacturing Cost Structure Analysis of Novel Coronavirus Inactivated Vaccine in 2025 Figure 72. Manufacturing Process Analysis of Novel Coronavirus Inactivated Vaccine Figure 73. Industry Chain Structure of Novel Coronavirus Inactivated Vaccine Figure 74. Channels of Distribution Figure 75. Global Novel Coronavirus Inactivated Vaccine Sales Market Forecast by Region (2026-2031) Figure 76. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share Forecast by Region (2026-2031) Figure 77. Global Novel Coronavirus Inactivated Vaccine Sales Market Share Forecast by Type (2026-2031) Figure 78. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share Forecast by Type (2026-2031) Figure 79. Global Novel Coronavirus Inactivated Vaccine Sales Market Share Forecast by Application (2026-2031) Figure 80. Global Novel Coronavirus Inactivated Vaccine Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Inovio Pharmaceuticals|||Moderna|||GlaxoSmithKline|||Pfizer|||Johnson&Johnson|||Heat Biologics|||Sanofi|||Beijing Institute of Biological Products Co., Ltd|||Beijing Kexing Zhongwei Biotechnology Co., Ltd|||Shanghai Pharmaceutical CanSino Biopharmaceutical Co., Ltd|||Wuhan Institute of Biological Products Co., Ltd